NCT06020300

Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI)

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: National University of Malaysia · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To Study Efficacy and safety oral colchicine 0.6 mg post ST Elevation myocardial infraction (STEMI)

Detailed description

Colchicine is a cheap and potent anti-inflammatory. We believe anti-inflammatory is able to reduce inflammation in coronary arteries and heart muscle post ST elevation myocardial infarction which may benefit in short and long term outcome in patients. The short term outcome is measured using serum troponin and long term outcome is assessed with transthoracic echocardiogram and major adverse cardiac events.

Conditions

• STEMI

Interventions

Type	Name	Description
DRUG	Oral Colchicine 0.6 mg	Anti-Inflammatory Effects
DRUG	Oral Pyridoxine 10 mg	Colchicine look alike placebo

Timeline

• Start date: 2023-07-28
• Primary completion: 2023-12-29
• Completion: 2024-05-31
• First posted: 2023-08-31
• Last updated: 2023-08-31

Locations

1 site across 1 country: Malaysia